First Horizon Advisors, Inc. Adaptive Biotechnologies Corp Transaction History

First Horizon Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$10.12 - $28.9 $2,955 - $8,438	-292 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $7,354 - $9,768	245 Added 521.28%	292 $9,000
Q3 2021 Nov 09, 2021	SELL	$30.02 - $39.87 $7,354 - $9,768	-245 Reduced 83.9%	47 $1,000
Q2 2021 Aug 09, 2021	BUY	$32.22 - $44.59 $9,408 - $13,020	292 New	292 $11,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.